HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target
Austin, Texas, United States, March 3rd, 2026, FinanceWire
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
- New report upgrades HeartBeam to buy, raises 12-month price target to $4, citing regulatory progress and company’s transition toward commercialization.
- Joseph Gunnar characterized the FDA clearance of HeartBeam’s 12-lead ECG synthesis software for arrhythmia assessment as a “critical regulatory milestone.”
- The research report underscores the company’s targeted go-to-market strategy.
Equity research reports often serve as important barometers of shifting sentiment, offering investors detailed analysis of a company’s strategy, risks and growth potential. In a new research note, Joseph Gunnar & Co. upgraded HeartBeam (NASDAQ:BEAT) from Hold to Buy and raised its 12-month price target to $4 from $1, citing regulatory progress and the company’s transition toward commercialization. A medical tech company, HeartBeam will introduce its FDA-cleared cable-free, synthesized 12-lead ECG system designed to deliver clinical-grade cardiac insights for arrhythmia assessment in a portable format, and the upgrade reflects growing confidence in the company’s commercial launch strategy and long-term opportunity.
“We upgrade HeartBeam to a BUY and High-Risk rating with a raised price target of $4 (from $1), reflecting progress in cardiac risk detection,” the February 2026 report states. The report highlights a significant turning point for the company following FDA clearance of its 12-lead ECG synthesis…
Read More>>
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
Contact
IBN
www.InvestorBrandNetwork.com
Editor@InvestorBrandNetwork.com
If you want to submit your press release through TipRanks NewsWire, please go to the following link.
